Ying Cheng

The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy

Xiaohu Zheng, Yingying Huang, Yaqi Wu, 2022, Cellular & Molecular Immunology.

All‐trans retinoic acid induces leukemia resistance to NK cell cytotoxicity by down‐regulating B7‐H6 expression via c‐Myc signaling

R. Sun, Z. Tian, Haiming Wei, 2021, Cancer communications.

Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager

R. Sun, Z. Tian, Haoyu Sun, 2023, Frontiers in Immunology.

Trispecific killer engager 161519 enhances natural killer cell function and provides anti-tumor activity against CD19-positive cancers

R. Sun, Z. Tian, Haiming Wei, 2020, Cancer biology & medicine.